FDAnews
www.fdanews.com/articles/149699-st-paul-drug-startup-being-acquired-for-100-million-in-cash

St. Paul Drug Startup Being Acquired for $100 Million in Cash

September 25, 2012
Mallinckrodt, the pharmaceuticals business of publicly held Covidien of Ireland, will pay $100 million in cash for St. Paul-based CNS Therapeutics, a five-year-old specialty pharmaceutical company.
Minneapolis Star Tribune